Steven Knapper

19PUBLICATIONS
105CO-AUTHORS
Models of care and place of birthHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 16, 2026
The leukaemia in pregnancy study, a national multicentre retrospective study of pregnancy outcomes in women with concurrent or historic diagnoses of acute leukaemia.

|Jun 25, 2026
Combining quizartinib with intensive chemotherapy for older patients with newly diagnosed AML: results of the UK NCRI AML18 trial.

|May 03, 2026
Real-world treatment patterns and outcomes in accelerated and blast-phase myeloproliferative neoplasms: Insights from a large multi-centre cohort analysis in the United Kingdom.

|Nov 14, 2025
CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial.

Steven Knapper, Laura W Dillon, Malavika Babu

|Sep 30, 2025
Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML.

Nigel Russell, Jad Othman, Oliver Cumming

|May 22, 2025
A revised prognostic model for patients with acute myeloid leukemia and first relapse.

Niek G van der Maas, Dimitri Breems, Clara P W Klerk

Pageof 4

Frequent Collaborators

11 joint publications

Sylvie Freeman

7 joint publications

Abin Thomas

6 joint publications

Priyanka Mehta

6 joint publications

Mary Frances McMullin